Electrophysiological predictors of early response to antidepressants in major depressive disorder
Hao Tang1, Yi Xia1, Lingling Hua1
1Department of Psychiatry, the Affiliated Brain Hospital of Nanjing Medical University, Nanjing 210029, China.
Background:
Psychomotor retardation (PMR) is a core feature of major depressive disorder (MDD), which is characterized by abnormalities in motor control and cognitive processes. PMR in MDD can predict a poor antidepressant response, suggesting that PMR may serve as a marker of the antidepressant response. However, the neuropathological relationship between treatment outcomes and PMR remains uncertain. Thus, this study examined electrophysiological biomarkers associated with poor antidepressant response in MDD.
Methods:
A total of 142 subjects were enrolled in this study, including 49 healthy controls (HCs) and 93 MDD patients. All participants performed a simple right-hand visuomotor task during magnetoencephalography (MEG) scanning. Patients who exhibited at least a 50 % reduction in disorder severity at the endpoint (>2 weeks) were considered to be responders. Motor-related beta desynchronization (MRBD) and inter- and intra-hemispheric functional connectivity were measured in the bilateral motor network.
Results:
An increased MRBD and decreased inter- and intra-hemispheric functional connectivity in the motor network during movement were observed in non-responders, relative to responders and HCs. This dysregulation predicted the potential antidepressant response.
Conclusion:
Abnormal local activity and functional connectivity in the motor network indicate poor psychomotor function, which might cause insensitivity to antidepressant treatment. This could be regarded as a potential neural mechanism for the prediction of a patient's treatment response.
Insights
Psychomotor retardation in major depressive disorder (MDD) is linked to poor antidepressant response. Specific motor network abnormalities detected via magnetoencephalography (MEG) can predict treatment outcomes in MDD patients.
Area of Science:
- Neuroscience
- Psychiatry
- Biomarkers
Background:
- Psychomotor retardation (PMR) is a key symptom of major depressive disorder (MDD), affecting motor control and cognition.
- PMR in MDD is associated with a diminished response to antidepressant treatments.
- The precise neural underpinnings linking PMR to treatment outcomes in MDD are not fully understood.
Purpose of the Study:
- To investigate electrophysiological biomarkers associated with poor antidepressant response in MDD patients.
- To explore the relationship between motor network function and treatment outcomes in depression.
Main Methods:
- Magnetoencephalography (MEG) was used to record brain activity in 93 MDD patients and 49 healthy controls (HCs) during a visuomotor task.
- Motor-related beta desynchronization (MRBD) and functional connectivity within the motor network were measured.
- Antidepressant response was defined as a ≥50% reduction in symptom severity after treatment.
Main Results:
- Non-responders exhibited increased MRBD and reduced inter- and intra-hemispheric functional connectivity in the motor network compared to responders and HCs.
- These motor network dysregulations were found to predict antidepressant treatment response.
- Abnormalities in local motor network activity and connectivity were observed in patients with poor treatment outcomes.
Conclusions:
- Altered motor network activity and connectivity are indicative of poor psychomotor function in MDD.
- These neural characteristics may contribute to reduced sensitivity to antidepressant therapies.
- Electrophysiological markers in the motor network show potential for predicting antidepressant treatment response in MDD.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
01:30Electroconvulsive Therapy